In fiscal year 2023, BioInfra (199730) reported revenue of 30.1 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2023 | 30.1 billion KRW | 1.3 billion KRW | 2.0 billion KRW | [source] |
| 2022 | 35.4 billion KRW | 6.4 billion KRW | 6.2 billion KRW | [source] |
| 2021 | 30.6 billion KRW | 7.5 billion KRW | 6.2 billion KRW | — |
| 2020 | 19.6 billion KRW | 3.6 billion KRW | 4.2 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2023 | 47.0 billion KRW | 13.0 billion KRW | 34.0 billion KRW | [source] |
| 2022 | 32.6 billion KRW | 14.7 billion KRW | 17.9 billion KRW | [source] |
| 2021 | — | — | — | — |
| 2020 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.